ECM
RNTX

Endurant Capital Management’s Rein Therapeutics RNTX Stock Holding History

Endurant Capital Management’s Portfolio RNTX Stock Details RNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,172
Closed -$340K – 77
2020
Q3 		$340K Buy
+13,172
New +$310K 0.12% 59
2018
Q2 		– Sell
-3,785
Closed -$615K – 80
2018
Q1 		$615K Sell
3,785
-515
-12% -$91.8K 0.23% 63
2017
Q4 		$906K Buy
4,300
+832
+24% +$199K 0.28% 60
2017
Q3 		$928K Sell
3,468
-987
-22% -$248K 0.28% 70
2017
Q2 		$993K Buy
+4,455
New +$978K 0.28% 67

Other funds holding RNTX

AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
GPFA
Game Plan Financial Advisors Westlake, Ohio $222M AUM 22.82% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $70.4B AUM 20.22% 1-Year Est. Return